Alterity Therapeutics Ltd Capital Reinvestment Ratio

Latest as of September 2023: 0.01x

Alterity Therapeutics Ltd capital reinvestment ratio. Alterity Therapeutics Ltd (ATH) has a Capital Reinvestment Ratio of 0.01x as of September 2023, meaning it reinvests 0% of its operating cash flow (AU$549.00K) in capital expenditures (AU$4.00K). Check cash flow reinvestment rate of Alterity Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

AU$549.00K

AUD

Capital Expenditures

AU$4.00K

AUD

Data as of

Sep 2023

Most recent filing

Alterity Therapeutics Ltd Capital Reinvestment Ratio by Year (None–None)

Alterity Therapeutics Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does Alterity Therapeutics Ltd generate cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow